Physician profile
Ferozuddin Amani
NPI 1962481523
$1,577.06
in general payments reported to CMS, 2019-2025
17 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $274 · 2023: $674 · 2024: $354 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $346.06 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $172.65 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $154.62 | 2022-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $154.35 | 2023 | Farxiga, Breztri |
| Abbvie INC. | $123.92 | 2023-2025 | |
| Alk-Abello, INC | $123.12 | 2023-2025 | Odactra, Grastek |
| Sanofi Pasteur INC. | $99.26 | 2022-2025 | |
| Glaxosmithkline, LLC. | $96.35 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Boston Scientific Corporation | $84.08 | 2022 | |
| Pfizer INC. | $66.05 | 2022-2024 | |
| Xeris Pharmaceuticals, INC. | $30.22 | 2023 | Gvoke Hypopen |
| Lilly USA, LLC | $30.05 | 2025 | Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $24.09 | 2022 | |
| Aimmune Therapeutics, INC. | $20.82 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.21 | 2025 | Xifaxan |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.48 | 2023 | Gardasil 9, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $15.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ferozuddin Amani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.